| Literature DB >> 25428509 |
Yoshio Nakata1, Masafumi Okada, Koichi Hashimoto, Yoshinori Harada, Hirohito Sone, Kiyoji Tanaka.
Abstract
OBJECTIVE: Our previous study, a 6-month randomised controlled trial, demonstrated that a group-based support promoted weight loss as compared to an education-only intervention. The purpose of this study was to examine weight loss maintenance for 2 years.Entities:
Mesh:
Year: 2014 PMID: 25428509 PMCID: PMC5644908 DOI: 10.1159/000369913
Source DB: PubMed Journal: Obes Facts ISSN: 1662-4025 Impact factor: 3.942
Fig. 1Flow diagram of the participant progress through the 30-month randomised trial.
Baseline characteristics of followed-up participants by treatment assignment
| Education-only (n = 62) | Group-based support (n = 63) | p-value | |
|---|---|---|---|
| Age, years | 51.7 (6.8) | 50.7 (6.7) | 0.414 |
| Women, no. (%) | 41 (66) | 51 (81) | 0.059 |
| Current smoker, no. (%) | 3 (5) | 3 (5) | 0.984 |
| Lipid-lowering therapy, no. (%) | 10 (16) | 3 (5) | 0.033 |
| Antihypertensive therapy, no. (%) | 16 (26) | 15 (24) | 0.796 |
| Height, cm | 160.0 (9.0) | 159.1 (7.2) | 0.577 |
| Weight, kg | 74.9 (12.1) | 73.5 (9.9) | 0.476 |
| BMI, kg/m2 | 29.2 (3.8) | 29.0 (3.0) | 0.670 |
| Waist circumference, cm | 100.7 (7.9) | 99.2 (7.3) | 0.269 |
| Systolic blood pressure, mm Hg | 131.2 (14.5) | 131.9 (16.4) | 0.793 |
| Diastolic blood pressure, mm Hg | 80.2 (7.4) | 79.9 (10.2) | 0.849 |
| Triglycerides, mmol/l | 1.57 (0.71) | 1.26 (0.59) | 0.009 |
| HDL cholesterol, mmol/l | 1.39 (0.34) | 1.49 (0.31) | 0.093 |
| Fasting plasma glucose, mmol/l | 5.50 (0.96) | 5.25 (0.59) | 0.079 |
| Energy intake, kcal/day | 2,181 (417) | 2,169 (414) | 0.880 |
| Step counts, step/day | 6,198 (2,740) | 6,435 (3,016) | 0.650 |
| MVPA, min/day | 86 (30) | 93 (35) | 0.191 |
HDL = High-density lipoprotein; MVPA = moderate-to-vigorous physical activity.
Data are presented as mean (standard deviation) unless otherwise specified.
p value of unpaired t-test or χ2 test at baseline between groups.
Data from 123 eligible participants were available (61 and 62 in the education-only and the group-based support groups, respectively).
Fig. 2Pattern of change in body weight by treatment assignment. Each data point represents the mean value for all randomised participants, with missing data replaced by the last observation carried forward at months 3 and 6 and by the baseline observation carried forward at months 18 and 30. Error bars indicate standard errors. Points and error bars are jittered horizontally to improve visibility.
Changes in primary and secondary outcome measures, energy intake, and physical activity by intention-to-treat analysis
| Education-only (n = 62) | Group-based support (n = 63) | p-value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| baseline | month 6 | month 30 | 30-month change | baseline | month 6 | month 30 | 30–month change | ||
| Weight, kg | 74.9 (12.1) | 70.2 (12.6) | 71.6 (12.5) | −3.3 | 73.5 (9.9) | 65.7 (9.5) | 70.2 (10.6) | −3.3 | 0.967 |
|
| |||||||||
| BMI, kg/m2 | 29.2 (3.8) | 27.4 (4.0) | 28.0 (4.0) | −1.3 | 29.0 (3.0) | 25.9 (3.0) | 27.7 (3.5) | −1.3 | 0.945 |
|
| |||||||||
| WC, cm | 100.7 (7.9) | 96.0 (9.1) | 96.1 (9.1) | −4.6 | 99.2 (7.3) | 91.1 (8.4) | 94.3 (8.5) | −4.9 | 0.773 |
|
| |||||||||
| SBP, mm Hg | 131.2 (14.5) | 120.5 (13.3) | 124.3 (13.3) | −6.9 | 131.9 (16.4) | 119.6 (18.1) | 126.4 (17.5) | −5.5 | 0.530 |
|
| |||||||||
| DBP, mm Hg | 80.2 (7.4) | 73.2 (9.1) | 74.9 (8.1) | −5.3 | 79.9 (10.2) | 71.3 (9.7) | 76.0 (10.3) | −3.9 | 0.322 |
|
| |||||||||
| TG, mmol/l | 1.57 (0.71) | 1.23 (0.68) | 1.36 (0.70) | −0.21 | 1.26 (0.59) | 0.95 (0.43) | 1.20 (0.65) | −0.06 | 0.113 |
|
| |||||||||
| HDL−C, mmol/l | 1.39 (0.34) | 1.44 (0.35) | 1.49 (0.39) | 0.10 | 1.49 (0.31) | 1.56 (0.35) | 1.55 (0.38) | 0.06 | 0.378 |
|
| |||||||||
| FPG, mmol/l | 5.50 (0.96) | 5.16 (0.82) | 5.36 (0.90) | −0.14 | 5.25 (0.59) | 4.91 (0.38) | 5.23 (0.56) | −0.01 | 0.084 |
|
| |||||||||
| Energy intake, kcal/day | 2,181 (417) | 1,799 (440) | 1,983 (416) | −197 | 2,169 (414) | 1,524 (354) | 1,918 (396) | −251 | 0.384 |
|
| |||||||||
| Step counts, step/day | 6,198 (2,740) | 7,468 (3,676) | 6,890 (3,455) | 692 | 6,435 (3,016) | 7,525 (3,326) | 6,916 (4310) | 481 | 0.667 |
|
| |||||||||
| MVPA, min/day | 86 (30) | 96 (37) | 90 (38) | 5 | 93 (35) | 99 (37) | 95 (45) | 2 | 0.565 |
DBP = Diastolic blood pressure; FPG = fasting plasma glucose; HDL-C = high-density lipoprotein cholesterol; MVPA = moderate-to-vigorous physical activity; SBP =systolic blood pressure; TG = triglycerides; WC = waist circumference.
Data at baseline and months 6 and 30 are presented as mean (standard deviation). Changes from baseline to month 30 are presented as mean (95% confidence interval).
p value of unpaired t-test for 30-month change between groups.
Data from 123 eligible participants were available (61 and 62 in the education-only and the group-based support groups, respectively).
Baseline characteristics and changes in outcome measures based on quartiles of percent weight lossa
| Percent weight loss at 30 months | p-valueb | ||||
|---|---|---|---|---|---|
| 1st quartile (n = 25) | 2nd quartile (n = 25) | 3rd quartile (n = 25) | 4th quartile (n = 25) | ||
| Age, years | 50.6 (6.6) | 51.3 (7.0) | 52.4 (7.9) | 51.0 (6.2) | 0.813 |
| Women, no. (%) | 16 (64) | 21 (84) | 20 (80) | 16 (64) | 0.230 |
| Group-based support, no. (%) | 10 (40) | 14 (56) | 12 (48) | 13 (52) | 0.704 |
| Current smoker, no. (%) | 1 (4) | 1 (4) | 2 (8) | 0 (0) | 0.414 |
| Lipid-lowering therapy, no. (%) | 2 (8) | 3 (12) | 4 (16) | 2 (8) | 0.778 |
| Antihypertensive therapy, no. (%) | 5 (20) | 8 (32) | 6 (24) | 4 (16) | 0.582 |
| Height, cm | 162.1 (9.7) | 157.5 (5.8) | 157.5 (6.6) | 161.4 (8.2) | 0.074 |
| Weight, kg | |||||
| Baseline | 75.0 (12.8) | 73.0 (8.2) | 74.1 (12.0) | 74.3 (10.6) | 0.931 |
| Changes | +1.4 (1.6) | −1.8 (0.7) | −5.0 (1.8) | −10.9 (4.2) | <0.001 |
| BMI, kg/m2 | |||||
| Baseline | 28.4 (2.9) | 29.4 (3.7) | 29.8 (3.9) | 28.4 (2.3) | 0.312 |
| Changes | +0.5 (0.6) | −0.7 (0.2) | −2.0 (0.6) | −4.2 (1.5) | <0.001 |
| WC, cm | |||||
| Baseline | 99.4 (7.0) | 100.2 (8.8) | 101.8 (7.8) | 98.8 (5.3) | 0.500 |
| Changes | −0.4 (4.4) | −3.6 (3.1) | −7.4 (3.3) | −12.1 (5.2) | <0.001 |
| SBP, mm Hg | |||||
| Baseline | 128.5 (16.6) | 132.6 (12.7) | 136.3 (16.5) | 129.3 (13.3) | 0.242 |
| Changes | −4.7 (9.9) | −3.2 (14.9) | −11.0 (14.4) | −12.0 (13.0) | 0.045 |
| DBP, mm Hg | |||||
| Baseline | 78.2 (8.2) | 80.9 (7.6) | 79.8 (7.7) | 80.2 (9.2) | 0.686 |
| Changes | −4.2 (7.9) | −5.7 (9.6) | −4.4 (7.3) | −8.7 (8.9) | 0.222 |
| TG, mmol/l | |||||
| Baseline | 1.57 (0.80) | 1.29 (0.51) | 1.34 (0.50) | 1.45 (0.63) | 0.397 |
| Changes | −0.08 (0.52) | +0.00 (0.51) | −0.07 (0.58) | −0.52 (0.58) | 0.004 |
| HDL-C, mmol/l | |||||
| Baseline | 1.41 (0.32) | 1.49 (0.28) | 1.48 (0.28) | 1.41 (0.40) | 0.738 |
| Changes | +0.02 (0.21) | +0.00 (0.18) | +0.04 (0.24) | +0.36 (0.30) | <0.001 |
| FPG, mmol/l | |||||
| Baseline | 5.28 (0.90) | 5.34 (0.58) | 5.62 (1.13) | 5.31 (0.65) | 0.460 |
| Changes | +0.03 (0.30) | −0.09 (0.37) | −0.07 (0.56) | −0.27 (0.63) | 0.191 |
| Energy intake, kcal/day | |||||
| Baseline | 2,189 (467) | 2,082 (321) | 2,118 (318) | 2,223 (488) | 0.602 |
| Changes | −226 (443) | −219 (274) | −331 (386) | −345 (352) | 0.492 |
| Step counts, step/dayc | |||||
| Baseline | 6,210 (2,748) | 6,784 (2,727) | 6,167 (3,076) | 6,925 (3,516) | 0.752 |
| Changes | −33 (1,142) | +379 (2,924) | +65 (2,705) | +2,607 (4,000) | 0.005 |
| MVPA, min/dayc | |||||
| Baseline | 87 (33) | 93 (28) | 91 (36) | 94 (35) | 0.883 |
| Changes | −4 (18) | +5 (28) | −3 (30) | +21 (41) | 0.018 |
DBP = Diastolic blood pressure; FPG = fasting plasma glucose; HDL-C = high-density lipoprotein cholesterol; MVPA = moderate-to-vigorous physical activity; SBP = systolic blood pressure; TG = triglycerides; WC= waist circumference.
Data are presented as mean (standard deviation) unless otherwise specified.
p value of one-way analysis of variance or χ2 test among groups.
Data from 97 eligible participants were available (25, 25, 23 and 24 in the 1st, 2nd, 3rd, and 4th quartile groups, respectively).